Cardiac Allograft Rejection

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Springer US

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-1-4615-1649-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.

  2003cited by this paper
• Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

  2003cited by this paper
• Moderate acute rejection detected during annual catheterization in pediatric heart transplant recipients.

  2003cited by this paper
• Troponin T and I are not reliable markers of cardiac transplant rejection.

  2002cited by this paper
• Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome.

  2002cited by this paper
• Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence.

  2001cited by this paper
• Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence.

  2001cited by this paper
• Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation.

  2001cited by this paper
• Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy.

  2001cited by this paper
• Influence of cold ischemia time on hyperacute rejection and delayed graft function of porcine kidneys following discordant xenotransplantation from pig to cynomolgus monkey.

  2001cited by this paper
• Reliability of Tissue Doppler Wall Motion Monitoring After Heart Transplantation for Replacement of Invasive Routine Screenings by Optimally Timed Cardiac Biopsies and Catheterizations

  2001cited by this paper
• Lumen Loss in Transplant Coronary Artery Disease Is a Biphasic Process Involving Early Intimal Thickening and Late Constrictive Remodeling Results From a 5-Year Serial Intravascular Ultrasound Study

  2001cited by this paper
• Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody.

  2000cited by this paper
• The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection.

  2000cited by this paper
• Radionuclide imaging of acute lung transplant rejection with annexin V.

  2000cited by this paper
• Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation.

  2000cited by this paper
• The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000.

  2000cited by this paper
• Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation.

  2000cited by this paper
• Visualisation of cell death in vivo in patients with acute myocardial infarction.

  2000cited by this paper
• Radioimaging to identify myocardial cell death and probably injury.

  2000cited by this paper
• PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS

  2000cited by this paper
• 99mTc Annexin V Imaging of Neonatal Hypoxic Brain Injury

  2000cited by this paper
• Cardiac allograft vasculopathy

  2000cited by this paper
• Neoral use in the cardiac transplant recipient.

  2000cited by this paper
• Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection.

  2000cited by this paper
• Myocardial cell damage in human hypertension.

  2000cited by this paper
• "Annexinopathies"--a new class of diseases.

  1999cited by this paper
• Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine 1

  1999cited by this paper
• Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.

  1999cited by this paper
• Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.

  1999cited by this paper
• Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation.

  1999cited by this paper
• Dying a thousand deaths. Radionuclide imaging of apoptosis.

  1999cited by this paper
• Annexin V counteracts apoptosis while inducing Ca(2+) influx in human lymphocytic T cells.

  1999cited by this paper
• Oral steroid pulse without taper for the treatment of asymptomatic moderate cardiac allograft rejection.

  1999cited by this paper
• A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.

  1999cited by this paper
• Viral and Bacterial Infections Interfere with Peripheral Tolerance Induction and Activate CD8+ T Cells to Cause Immunopathology

  1998cited by this paper
• Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure.

  1998cited by this paper
• Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation.

  1998cited by this paper
• Tolerization of Anti–Galα1-3Gal Natural Antibody–forming B Cells by Induction of Mixed Chimerism

  1998cited by this paper
• CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

  1998cited by this paper
• Persistence of Peptide-induced CD4+ T cell Anergy In Vitro

  1998cited by this paper
• Relation between the kinetics of thallium-201 in myocardial scintigraphy and myocardial metabolism in patients with acute myocardial infarction

  1998cited by this paper
• Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging.

  1998cited by this paper
• Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation.

  1998cited by this paper
• Therapeutic monitoring of mycophenolic acid: A consensus panel report

  1998cited by this paper
• Extrathymic T Cell Deletion and Allogeneic Stem Cell Engraftment Induced with Costimulatory Blockade Is Followed by Central T Cell Tolerance

  1998cited by this paper
• Xenoantigens and xenoantibodies

  1998cited by this paper
• Xenogeneic transplantation.

  1998cited by this paper
• Revision of the 1990 working formulation for cardiac allograft rejection: the Sheffield experience

  1998cited by this paper
• Risk factors for early mortality, acute rejection, and factors affecting first-year survival after heart transplantation.

  1998cited by this paper
• Separate regulation of peripheral hematopoietic and thymic engraftment.

  1998cited by this paper
• Orthotopic heart transplantation in a transgenic pig-to-primate model.

  1998cited by this paper
• The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection.

  1998cited by this paper
• Absent myocardial iodine-123-BMIPP uptake and platelet/monocyte CD36 deficiency.

  1998cited by this paper
• IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.

  1998cited by this paper
• The role of T-cell costimulatory activation pathways in transplant rejection.

  1998cited by this paper
• Effects of pravastatin on chronic rejection of rat cardiac allografts.

  1998cited by this paper
• Apoptosis in the failing heart.

  1998cited by this paper
• Prevention of cardiac hypertrophy in mice by calcineurin inhibition.

  1998cited by this paper
• In vivo detection and imaging of phosphatidylserine expression during programmed cell death.

  1998cited by this paper
• Tolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cells.

  1998cited by this paper
• Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database.

  1998cited by this paper
• Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen.

  1998cited by this paper
• Plasmapheresis as therapy to resolve vascular rejection in heart transplantation with severe heart failure: "a report of one case".

  1998cited by this paper
• Noninvasive detection of allograft rejection in heart transplant recipients by use of Doppler tissue imaging.

  1998cited by this paper
• Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine.

  1998cited by this paper
• A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

  1998cited by this paper
• Apoptosis is involved in acute cardiac allograft rejection in rats.

  1998cited by this paper
• Molecular imaging of atherosclerosis using a technetium-99m-labeled endothelin derivative.

  1998cited by this paper
• Apoptosis of mononuclear cell infiltrates in cardiac allograft biopsy specimens questions studies of biopsy-cultured cells.

  1997cited by this paper
• Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys.

  1997cited by this paper
• Sequential change of BMIPP uptake with age in spontaneously hypertensive rat model

  1997cited by this paper
• Pharmacokinetics of Sirolimus in Stable Renal Transplant Patients after Multiple Oral Dose Administration

  1997cited by this paper
• A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

  1997cited by this paper
• SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.

  1997cited by this paper
• Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning

  1997cited by this paper
• FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.

  1997cited by this paper
• Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.

  1997cited by this paper
• Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood.

  1997cited by this paper
• Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression.

  1997cited by this paper
• SDZ RAD, a new rapamycin derivative: synergism with cyclosporine.

  1997cited by this paper
• Balancing the immune system for tolerance: a case for regulatory CD4 cells.

  1997cited by this paper
• Treatment of Severe Acute Vascular Rejection in a Renal Allograft with Mycophenolate Mofetil and High Dose Steroids

  1997cited by this paper
• The CD40 pathway in allograft rejection, acceptance, and tolerance.

  1997cited by this paper
• Role of transplantation (lung, liver, and heart) in sarcoidosis.

  1997cited by this paper
• Freehand three-dimensional echocardiography for measurement of left ventricular mass: in vivo anatomic validation using explanted human hearts.

  1997cited by this paper
• Performances of Doppler echocardiography for diagnosis of acute, mild, or moderate cardiac allograft rejection.

  1997cited by this paper
• Oral tolerance: immune mechanisms and treatment of autoimmune diseases.

  1997cited by this paper
• Effect of mycophenolic acid glucuronide on inosine monophosphate dehydrogenase activity.

  1997cited by this paper
• Accommodation of vascularized xenografts: Expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment

  1997cited by this paper
• Characterization of pigs transgenic for human decay-accelerating factor.

  1997cited by this paper
• Genetic Engineering as an Approach to Xenotransplantation

  1997cited by this paper
• Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

  1997cited by this paper
• Microchimerism and rejection in clinical transplantation.

  1997cited by this paper
• Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?

  1997cited by this paper
• Specific tolerance induction and transplantation: a single-day protocol.

  1997cited by this paper
• Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database.

  1997cited by this paper
• Causes of late failure after heart transplantation: a ten-year survey.

  1997cited by this paper
• Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.

  1997cited by this paper
• Mycophenolate mofetil added to immunosuppression after liver transplantation – first results

  1997cited by this paper

• Incidence of acute cellular rejection and non-cellular rejection in cardiac transplantation.

  2004cites this paper